EAM
ALDX icon

Eagle Asset Management’s Aldeyra Therapeutics ALDX Stock Holding History

Eagle Asset Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.92M Sell
709,518
-132,053
-16% -$629K 0.02% 413
2024
Q2 		$2.74M Sell
841,571
-126,244
-13% -$494K 0.01% 444
2024
Q1 		$3.16M Sell
967,815
-42,519
-4% -$140K 0.02% 435
2023
Q4 		$3.55M Sell
1,010,334
-32,061
-3% -$98.9K 0.02% 413
2023
Q3 		$6.96M Sell
1,042,395
-16,151
-2% -$120K 0.04% 315
2023
Q2 		$8.88M Sell
1,058,546
-785,464
-43% -$7.74M 0.05% 278
2023
Q1 		$18.3M Buy
1,844,010
+72,321
+4% +$511K 0.11% 171
2022
Q4 		$12.3M Buy
1,771,689
+313,681
+22% +$1.79M 0.08% 212
2022
Q3 		$7.79M Sell
1,458,008
-47,930
-3% -$288K 0.05% 272
2022
Q2 		$6.01M Buy
1,505,938
+32,479
+2% +$112K 0.04% 321
2022
Q1 		$6.55M Buy
1,473,459
+80,523
+6% +$321K 0.03% 346
2021
Q4 		$5.66M Buy
1,392,936
+46,468
+3% +$354K 0.02% 389
2021
Q3 		$11.8M Buy
1,346,468
+260,950
+24% +$2.39M 0.05% 282
2021
Q2 		$12.3M Buy
+1,085,518
New +$13.1M 0.05% 285

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Eagle Asset Management's ALDX Position: Q3 2024 in Review

Eagle Asset Management reduced its Aldeyra Therapeutics (ALDX) stake by 16% in Q3 2024, selling an estimated $629K and leaving 709,518 shares worth $3.92M. The position accounts for 0.02% of the portfolio, ranked #413.

Eagle Asset Management first reported a position in ALDX in Q2 2021 and has held it in 14 quarters since. The position peaked at $18.3M in Q1 2023. 112 funds tracked by Wall St. Rank hold ALDX as of Q3 2024.

  • Eagle Asset Management held 709,518 shares of Aldeyra Therapeutics worth $3.92M as of Q3 2024.
  • Eagle Asset Management sold 132,053 Aldeyra Therapeutics shares in Q3 2024, an estimated $629K.
  • Aldeyra Therapeutics made up 0.02% of Eagle Asset Management's portfolio in Q3 2024, its #413 holding.
  • Eagle Asset Management first reported a position in Aldeyra Therapeutics in Q2 2021 and has held it in 14 quarters since.
  • Eagle Asset Management's Aldeyra Therapeutics position peaked at $18.3M in Q1 2023.
  • 112 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.